Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS) FI
NCT ID: NCT04444583
Last Updated: 2025-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
155 participants
OBSERVATIONAL
2020-06-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events
NCT04882449
Identification of Heart Failure Patients by Seismocardiography
NCT03656354
Remote Monitoring of Cardiac Mechanics in Heart Failure Patients
NCT06885164
Network Medicine Approaches to Classify Heart Failure With PReserved Ejection Fraction by Signatures of DNA Methylation and Point-of-carE Risk calculaTors (PRESMET)
NCT05475028
Biomarkers to Classify Heart Failure
NCT02347722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HFpEF
HF patients with preserved ejection fraction (HFpEF)
No interventions assigned to this group
HFrEF
HF patients with reduced ejection fraction (HFrEF)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients visiting hospital for heart failure, either outpatient clinic or cardiac ward
* Signed informed consent as an acceptance to participate to the trial
Exclusion Criteria
* Severe cardiac valve disease
* Previous prosthetic cardiac valve
* Major adverse cardiovascular event or surgery within 6 weeks of planned study enrollment
* Patients with pacemaker
* Informed consent form not signed.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Turku University Hospital
OTHER_GOV
Helsinki University Central Hospital
OTHER
Precordior Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antti Saraste, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Heart Center Turku University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heart and Lung Center at Helsinki University Hospital
Helsinki, , Finland
Heart Center at Turku University Hospital
Turku, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REFLECS-FI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.